Life Tech CEO Says Renewed Licensing Effort, Digital PCR Patents Will Spur Royalties
January 14, 2010
Life Tech CEO Says Renewed Licensing Effort, Digital PCR Patents Will Spur Royalties
A new licensing team at Life Technologies helped reduce the decline in 2009 PCR patent royalties to around $20 million instead of $30 million, and it appears that 2010 will see no deterioration at all.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- PCR Systems, H1N1 Products Drive Q4, Full-Year Growth in Life Tech's Molecular Bio Business
January 28, 2010 / PCR Insider - Life Tech, Idaho Sign Cross-Licensing Pact Covering TaqMan, SYBR Green, Other PCR IP
January 28, 2010 / PCR Insider - Life Tech Acquisition Would Make Thermo Fisher a Leader in PCR Research Tools, Forensic Analysis
April 18, 2013 / PCR Insider - People in the News
May 5, 2011 / PCR Insider - Life Tech Developing CastPCR Method to Detect Rare Tumor Cells in FFPE Tissue, Blood
September 16, 2010 / PCR Insider